These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Stewart R, Herlyn M. Cancer Res; 1989 Sep 15; 49(18):5091-6. PubMed ID: 2548711 [Abstract] [Full Text] [Related]
30. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Vogt T, Stolz W, Welsh J, Jung B, Kerbel RS, Kobayashi H, Landthaler M, McClelland M. Clin Cancer Res; 1998 Mar 15; 4(3):791-7. PubMed ID: 9533549 [Abstract] [Full Text] [Related]
31. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC, Fisher PB. Oncogene; 2002 Jan 24; 21(5):708-18. PubMed ID: 11850799 [Abstract] [Full Text] [Related]
39. met and HGF-SF in normal melanocytes and melanoma cells. Halaban R, Rubin JS, White W. EXS; 1993 Sep 15; 65():329-39. PubMed ID: 8380740 [Abstract] [Full Text] [Related]
40. The melanoma growth stimulatory activity receptor consists of two proteins. Ligand binding results in enhanced tyrosine phosphorylation. Cheng QC, Han JH, Thomas HG, Balentien E, Richmond A. J Immunol; 1992 Jan 15; 148(2):451-6. PubMed ID: 1729365 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]